- Investing Ideas
- Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
7
Mid-Large Cap Stocks
7 companies
BioGaia
Market Cap: SEK 12.0b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 115.80
7D
-4.8%
1Y
17.7%
Vitrolife
Market Cap: SEK 12.3b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 88.75
7D
-7.5%
1Y
-34.7%
AddLife
Market Cap: SEK 19.0b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 156.40
7D
-2.7%
1Y
-11.7%
Camurus
Market Cap: SEK 30.9b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 514.50
7D
-6.1%
1Y
-13.3%
Bonesupport Holding
Market Cap: SEK 13.9b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 202.00
7D
-8.1%
1Y
-24.1%
BioArctic
Market Cap: SEK 26.6b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 314.00
7D
6.2%
1Y
78.5%
Swedish Orphan Biovitrum
Market Cap: SEK 152.2b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 444.80
7D
2.3%
1Y
60.7%